The mechanism of ovulation inhibition by triamcinolone acetonide

J Clin Endocrinol Metab. 1978 Jan;46(1):8-14. doi: 10.1210/jcem-46-1-8.

Abstract

A single dose of 25 mg triamcinolone acetonide, when given on day 1 or 2 of the menstrual cycle, inhibits ovulation. To examine the mechanism of this action, daily determinations of plasm FSH, LH, estrone plus estradiol (E1 + E2), and progestins were performed. Some subjects also received a single dose of LH-RH or hCG on cycle day 15 or clomiphene citrate on days 5-9. Triamcinolone acetonide itself caused variable suppression of plasma estrogens, loss of the mid-cycle gonadotropin surge, and a deficient or absent rise in plasma progestins. Impaired secretion of estrogen did not seem to be due to low gonadotropin levels. FSH and LH responses to LH-RH were adequate in relation to prevailing estrogen levels. Four of six women treated with clomiphene responded with plasma progestin levels which exceed 8 ng/ml. Triamcinolone acetonide seems to affect the hypothalamic-pituitary-ovarian axis mainly by hypothalamic suppression and possibly by a direct effect on the ovary as well.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Chorionic Gonadotropin / pharmacology
  • Clomiphene / pharmacology
  • Estrogens / blood
  • Female
  • Follicle Stimulating Hormone / blood
  • Gonadotropin-Releasing Hormone / pharmacology
  • Humans
  • Luteinizing Hormone / blood
  • Menstruation
  • Ovulation / drug effects*
  • Progestins / blood
  • Triamcinolone Acetonide / pharmacology*

Substances

  • Chorionic Gonadotropin
  • Estrogens
  • Progestins
  • Clomiphene
  • Gonadotropin-Releasing Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Triamcinolone Acetonide